Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Saved in:
Bibliographic Details
Title: Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
Authors: Kwon JM; American Family Children's Hospital, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. kwon@neurology.wisc.edu., Munell F; Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Le Goff L; Department of Physical Medicine and Rehabilitation, Hôpital Femme Mère Enfant - Hospices Civils de Lyon, Lyon, France., Yuge K; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan., Kato T; Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan., Cances C; Department of Paediatric Neurology, Reference Centre for Neuromuscular Disorders AOC, and Paediatric Clinical Research Unit Children's Hospital, Toulouse University Hospital Center, Toulouse, France., De Waele L; Department of Paediatric Neurology, Neuromuscular Reference Centre for Children, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium., Woodcock IR; Department of Neurology, The Royal Children's Hospital, Melbourne, Victoria, Australia.; The Murdoch Children's Research Institute, Parkville, Victoria, Australia., Mercuri EM; Paediatric Neurology, Catholic University, Rome, Italy.; Nemo Clinical Centre, Fondazione Policlinico Gemelli, IRCCS, Rome, Italy., Proud CM; Children's Hospital of The King's Daughters, Norfolk, VA, USA., Darras BT; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Hayes LH; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Oskoui M; Departments of Neurology and Neurosurgery and Pediatric, McGill University, Montreal, Quebec, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Visootsak J; Novartis Pharmaceuticals, East Hanover, NJ, USA., Williams G; Novartis Pharmaceuticals, London, UK., Ilić A; Novartis Pharmaceuticals, Basel, Switzerland., Yang L; Novartis Pharmaceuticals, East Hanover, NJ, USA., van der Pol WL; UMC Utrecht Brain Center, Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Source: Nature medicine [Nat Med] 2026 Feb; Vol. 32 (2), pp. 763.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-026-04233-9